What are the side effects and potential serious adverse events of Slynd (drospirenone‑estradiol) oral contraceptive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Slynd Side Effects

Slynd (drospirenone 4 mg progestin-only pill) carries both common and serious side effects, with the most critical being hyperkalemia risk, venous thromboembolism, and irregular menstrual bleeding. 1

Most Common Side Effects

The frequently reported side effects of Slynd include 1:

  • Acne
  • Headache
  • Breast pain and tenderness
  • Weight gain
  • Menstrual cramps
  • Nausea
  • Severe vaginal bleeding
  • Decreased sexual desire

Irregular vaginal bleeding is particularly common with Slynd, including spotting between periods, irregular periods, or complete absence of menstrual periods. While these bleeding changes are typically not dangerous, they should be reported to your healthcare provider 1.

Serious Side Effects Requiring Immediate Medical Attention

Hyperkalemia (High Potassium Levels)

This is the most unique and potentially dangerous side effect of Slynd due to drospirenone's anti-mineralocorticoid properties. Seek emergency care if you experience 1:

  • Weakness or numbness in arms or legs
  • Heart palpitations or irregular heartbeat
  • Nausea or vomiting
  • Severe chest pain
  • Shortness of breath

Critical caveat: You should have potassium levels checked before starting Slynd and during the first month if you take certain medications chronically (antifungals like ketoconazole, HIV/Hepatitis C medications, or clarithromycin) 1.

Venous Thromboembolism (Blood Clots)

Research evidence shows drospirenone-containing contraceptives carry increased VTE risk. A large Israeli cohort study found drospirenone increased venous thrombotic event risk 1.43-fold compared to third-generation oral contraceptives 2. A systematic review confirmed incidence rates of 23.0-136.7 per 100,000 woman-years 3.

Seek emergency care immediately for 1:

  • Leg pain that won't resolve
  • Sudden severe headache unlike usual headaches
  • Sudden severe shortness of breath
  • Sudden vision changes or blindness
  • Chest pain
  • Weakness or numbness in arm or leg
  • Trouble speaking

Other Serious Adverse Events

Ectopic pregnancy: If severe abdominal pain occurs, seek immediate care as pregnancy outside the uterus is a medical emergency 1.

Liver problems: Yellowing of skin or eyes (jaundice) requires immediate provider contact 1.

Depression: Particularly concerning if you have prior depression history. Contact your provider immediately if you have thoughts of self-harm 1.

Bone loss: Unknown whether the hormonal changes with Slynd result in decreased bone density 1.

Cervical cancer risk: Mentioned as a potential concern 1.

Absolute Contraindications

Do not take Slynd if you have 1:

  • Kidney disease or kidney failure
  • Reduced adrenal gland function (adrenal insufficiency)
  • Liver disease, including liver tumors
  • Cervical cancer or hormone-sensitive cancers
  • Unexplained vaginal bleeding

Special Monitoring Considerations

For diabetic patients: Blood sugar monitoring may need to be increased or diabetes medications adjusted 1.

Drug interactions: Slynd can affect other medications and vice versa. Inform providers about all medications, including St. John's Wort 1.

Laboratory tests: Slynd may affect certain blood test results, so inform lab personnel you're taking this medication 1.

Important Clinical Context

While newer estetrol/drospirenone formulations show promise for improved safety profiles with less hepatic and hemostatic impact than ethinyl estradiol-containing pills 4, 5, Slynd contains only drospirenone without estrogen, making it a progestin-only pill with its own distinct risk profile. The anti-mineralocorticoid activity that distinguishes drospirenone from other progestins creates the unique hyperkalemia risk that requires specific monitoring 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.